SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Lone Star Bio
Wearable Electronic Health Patches May Now Be Cheaper And Easier To Make, University of Texas Study
September 30, 2015
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Job Trends
Novartis AG Opens Up $53 Million Global Data Center at Alcon in Texas
September 30, 2015
 · 
3 min read
Lone Star Bio
Prototype Lab In A Needle Could Make Real-Time, Mobile Laboratory Testing A Reality, Houston Methodist Study
September 28, 2015
 · 
4 min read
Lone Star Bio
Plum Good Health Benefits, Texas A&M University Study
September 28, 2015
 · 
3 min read
Is Hilary Clinton The Anti-Biotech Candidate?
Biotech Bay
BioPharm Executive: Is Hillary Clinton the Anti-Biotech Candidate?
September 23, 2015
 · 
5 min read
Newest WikiLeaks Dump of Clinton Emails Exposes Some Biopharma Chatter
Bio NC
Will the Presidential Election Change the Face of the Way Prescription Drugs are Sold in the United States?
September 23, 2015
 · 
1 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Business
Biogen Wants to Go Beyond Drugs, Eyes Medtech
September 23, 2015
 · 
4 min read
Lone Star Bio
McDonald’s Investor Wants It To Cut Antibiotics In All Meats
September 18, 2015
 · 
1 min read
The 5 Most Exciting Biotech Jobs
Biotech Beach
5 Biotech Jobs That Won’t Bore You
September 10, 2015
 · 
3 min read
Cover Letters: Wow The Employer In 30 Seconds Or Less
Biotech Beach
Cover Letters: Wow The Employer In 30 Seconds Or Less
September 10, 2015
 · 
3 min read
Load More
PRESS RELEASES
Press Releases
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - March 7, 2025
March 10, 2025
 · 
2 min read
Press Releases
Lexicon Pharmaceuticals to Present at the Leerink Partners Global Healthcare Conference 2025
March 7, 2025
 · 
1 min read
Press Releases
New Data to be Presented at the 2025 American Academy of Dermatology (AAD) Annual Meeting Further Strengthens Evidence Supporting the Clinical Value of Castle Biosciences’ Dermatology Portfolio
March 7, 2025
 · 
8 min read
Press Releases
Plus Therapeutics Announces Peer-Reviewed Publication in Nature Communications Highlighting Promising Phase 1 Results for Rhenium (186Re) Obisbemeda in Glioblastoma
March 7, 2025
 · 
1 min read
Press Releases
Plus Therapeutics Granted U.S. FDA Orphan Drug Designation for Rhenium (186Re) Obisbemeda for the Treatment of Leptomeningeal Metastases in Patients with Lung Cancer
March 7, 2025
 · 
7 min read
Press Releases
ImmunoGenesis Doses First Patient in Phase 1/2 Clinical Trial of IMGS-101 in Combination With Balstilimab (anti-PD-1) and Zalifrelimab (anti-CTLA-4) in Relapsed or Refractory Advanced Prostate, Pancreatic, and HPV(-) Head & Neck Tumors
March 6, 2025
 · 
4 min read
Press Releases
Lexicon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
March 6, 2025
 · 
15 min read
Press Releases
Phantom Neuro Receives FDA Breakthrough Device and TAP Designations, Solidifying Position as a Neurotech Leader
March 6, 2025
 · 
3 min read
Press Releases
Autonomix Medical, Inc. Announces Abstract Highlighting Technology and Early Proof-of-Concept Study Results Accepted at the Society of Interventional Radiology (SIR) Annual Scientific Meeting
March 6, 2025
 · 
3 min read
Press Releases
bioAffinity Technologies Announces Targeted Actions to Cut $4 Million in Costs and Drive CyPath® Lung Sales Growth
March 6, 2025
 · 
6 min read
Load More